Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration

Nature Communications

Volumn 5, Issue , 2014, Pages

  Elabd, Christian ^a,b   Cousin, Wendy ^a,b   Upadhyayula, Pavan ^a,b   Chen, Robert Y ^a,b   Chooljian, Marc S ^a,b   Li, Ju ^a,b   Kung, Sunny ^a,b   Jiang, Kevin P ^a,b   Conboy, Irina M ^a,b  

^a Berkeley   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN HEAVY CHAIN; OXYTOCIN; TRANSCRIPTION FACTOR PAX7;

ANIMAL; HORMONE; MUSCLE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROBLAST; GASTROCNEMIUS MUSCLE; HOMEOSTASIS; IMMUNOCOMPETENT CELL; LIPID STORAGE; MALE; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MUSCLE MAINTENANCE; MUSCLE MASS; MUSCLE REGENERATION; NONHUMAN; OXYTOCIN BLOOD LEVEL; PROTEIN EXPRESSION; REJUVENATION; SATELLITE CELL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STEM CELL; SUBCUTANEOUS FAT; TIBIALIS ANTERIOR MUSCLE; WNT SIGNALING PATHWAY; AGING; ANIMAL; CULTURE TECHNIQUE; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; REGENERATION; SARCOPENIA; SKELETAL MUSCLE SATELLITE CELL;

AGING; ANIMALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; HOMEOSTASIS; MAP KINASE SIGNALING SYSTEM; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OXYTOCIN; REGENERATION; SARCOPENIA; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELLS;

EID: 84902317419     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5082     Document Type: Article

References (50)

1. Berger, M. J. & Doherty, T. J. Sarcopenia: prevalence, mechanisms, and functional consequences. Interdiscip. Top Gerontol. 37, 94-114 (2010).
2. Walston, J. D. Sarcopenia in older adults. Curr. Opin. Rheumatol. 24, 623-627 (2012).
3. Conboy, I. M. & Rando, T. A. Heterochronic parabiosis for the study of the effects of ageing on stem cells and their niches. Cell Cycle 11, 2260-2267 (2012).
4. Conboy, I. M. et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433, 760-764 (2005). (Pubitemid 40292986)
5. Brack, A. S. et al. Increased Wnt signaling during ageing alters muscle stem cell fate and increases fibrosis. Science 317, 807-810 (2007). (Pubitemid 47257918)
6. Villeda, S. A. et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90-94 (2011).
7. Ruckh, J. M. et al. Rejuvenation of regeneration in the ageing central nervous system. Cell Stem Cell 10, 96-103 (2012).
8. Salpeter, S. J. et al. Systemic regulation of the age-related decline of pancreatic b-cell replication. Diabetes 62, 2843-2848 (2013).
9. Loffredo, F. S. et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153, 828-839 (2013).
10. Carlson, M. E., Silva, H. S. & Conboy, I. M. ageing of signal transduction pathways, and pathology. Exp. Cell Res. 314, 1951-1961 (2008). (Pubitemid 351649367)
11. Elabd, C. et al. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells 26, 2399-2407 (2008).
12. Breton, C. et al. Presence of functional oxytocin receptors in cultured human myoblasts. J. Clin. Endocrinol. Metab. 87, 1415-1418 (2002). (Pubitemid 36121117)
13. Gimpl, G. & Fahrenholz, F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 81, 629-683 (2001). (Pubitemid 32267075)
14. Soloff, M. S., Schroeder, B. T., Chakraborty, J. & Pearlmutter, A. F. Characterization of oxytocin receptors in the uterus and mammary gland. Fed. Proc. 36, 1861-1866 (1977). (Pubitemid 8108365)
15. Lee, H.-J., Macbeth, A. H., Pagani, J. & Young, W. S. Oxytocin: the great facilitator of life. Prog. Neurobiol. 88, 127-151 (2009).
16. Tamma, R. et al. Oxytocin is an anabolic bone hormone. Proc. Natl Acad. Sci. USA 106, 7149-7154 (2009).
17. Camerino, C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring) 17, 980-984 (2009).
18. Takayanagi, Y. et al. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport 19, 951-955 (2008).
19. Deblon, N. et al. Mechanisms of the anti-obesity effects of oxytocin in dietinduced obese rats. PLoS ONE 6, e25565 (2011).
20. Beranger, G. E. et al. Oxytocin reverses ovariectomy-induced osteopenia and body fat gain. Endocrinology 155, 1340-1352 (2014).
21. Houshmand, F., Faghihi, M. & Zahediasl, S. Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats. Peptides 30, 2301-2308 (2009).
22. Kim, Y. S. et al. Priming of mesenchymal stem cells with oxytocin enhances the cardiac repair in ischemia/reperfusion injury. Cells Tissues Organs 195, 428-442 (2011).
23. Goldspink, G., Fernandes, K., Williams, P. E. &Wells, D. J. Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice. Neuromuscul. Disord. 4, 183-191 (1994). (Pubitemid 24171292)
24. Carlson, M. E., Hsu, M. & Conboy, I. M. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454, 528-532 (2008).
25. Conboy, I. M., Conboy, M. J., Smythe, G. M. & Rando, T. A. Notch-mediated restoration of regenerative potential to aged muscle. Science 302, 1575-1577 (2003). (Pubitemid 37475703)
26. Brack, A. S., Conboy, I. M., Conboy, M. J., Shen, J. & Rando, T. A. A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2, 50-59 (2008).
27. Paliwal, P., Pishesha, N., Wijaya, D. & Conboy, I. M. Age dependent increase in the levels of osteopontin inhibits skeletal muscle regeneration. ageing (Albany NY) 4, 553-566 (2012).
28. Cousin, W. et al. Regenerative capacity of old muscle stem cells declines without significant accumulation of DNA damage. PLoS ONE 8, e63528 (2013).
29. Volonte, D., Liu, Y. & Galbiati, F. The modulation of caveolin-1 expression controls satellite cell activation during muscle repair. FASEB J. 19, 237-239 (2005). (Pubitemid 40189267)
30. Kook, S.-H. et al. Cyclic mechanical stress suppresses myogenic differentiation of adult bovine satellite cells through activation of extracellular signal-regulated kinase. Mol. Cell Biochem. 309, 133-141 (2008).
31. Carlson, M. E. et al. Molecular ageing and rejuvenation of human muscle stem cells. EMBO Mol. Med. 1, 381-391 (2009).
32. Conboy, I. M., Yousef, H. & Conboy, M. J. Embryonic anti-ageing niche. ageing (Albany NY) 3, 555-563 (2011).
33. Yousef, H. et al. hESC-secreted proteins can be enriched for multiple regenerative therapies by heparin-binding. ageing (Albany NY) 5, 357-372 (2013).
34. Knight, J. D. & Kothary, R. The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis. Skelet. Muscle 1, 29 (2011).
35. Strakova, Z., Copland, J. A., Lolait, S. J. & Soloff, M. S. ERK2 mediates oxytocin-stimulated PGE2 synthesis. Am. J. Physiol. 274, E634-E641 (1998).
36. Lukjanenko, L., Brachat, S., Pierrel, E., Lach-Trifilieff, E. & Feige, J. N. Genomic profiling reveals that transient adipogenic activation is a hallmark of mouse models of skeletal muscle regeneration. PLoS ONE 8, e71084 (2013).
37. Pisani, D. F., Bottema, C. D. K., Butori, C., Dani, C. & Dechesne, C. A. Mouse model of skeletal muscle adiposity: a glycerol treatment approach. Biochem. Biophys. Res. Commun. 396, 767-773 (2010).
38. Uezumi, A., Fukada, S.-I., Yamamoto, N., Takeda, S. & Tsuchida, K. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat. Cell Biol. 12, 143-152 (2010).
39. Joe, A. W. B. et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat. Cell Biol. 12, 153-163 (2010).
40. Carlson, M. E. et al. Relative roles of TGF-beta1 and Wnt in the systemic regulation and ageing of satellite cell responses. ageing Cell 8, 676-689 (2009).
41. Murton, A. J. & Greenhaff, P. L. Resistance exercise and the mechanisms of muscle mass regulation in humans: acute effects on muscle protein turnover and the gaps in our understanding of chronic resistance exercise training adaptation. Int. J. Biochem. Cell Biol. 45, 2209-2214 (2013).
42. Gaugler, M. et al. PKB signaling and atrogene expression in skeletal muscle of aged mice. J. Appl. Physiol. (1985) 111, 192-199 (2011).
43. Baehr, L. M., Tunzi, M. & Bodine, S. C. Muscle hypertrophy is associated with increases in proteasome activity that is independent of MuRF1 and MAFbx expression. Front. Physiol. 5, 69 (2014).
44. Modahl, C. et al. Plasma oxytocin levels in autistic children. Biol. Psychiatry 43, 270-277 (1998). (Pubitemid 28085673)
45. Ruggeri, B., Sarkans, U., Schumann, G. & Persico, A. M. Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology (Berl) 78, 611-615 (2013).
46. Breuil, V. et al. Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition. Joint Bone Spine 78, 611-615 (2011).
47. Frasch, A., Zetzsche, T., Steiger, A. & Jirikowski, G. F. Reduction of plasma oxytocin levels in patients suffering from major depression. Adv. Exp. Med. Biol. 395, 257-258 (1995). (Pubitemid 26110860)
48. Barraza, J. A. et al. Effects of a 10-day oxytocin trial in older adults on health and well-being. Exp. Clin. Psychopharmacol. 21, 85-92 (2013).
49. Manning, M. et al. Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban. Int. J. Pept. Protein Res. 46, 244-252 (1995).
50. Manning, M. et al. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog. Brain Res. 170, 40 (2008).